NVG, LLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 20, 2025

Income

$120,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare coverage of Anti-Obesity Medicines.

Health Issues

Issues related to pharmaceutical supply chain transparency and integrity. Issues related to compounding and counterfeit medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.